Search research articles
Contact Us
Filters
Showing results (21-30 of 53) with videos related to
Page
of 6
Sort By:
Cancer Investigation
|
January 1, 1992
A pilot study of intensive weekly chemotherapy for extensive disease small-cell lung carcinoma
G L Wampler, J D Ahlgren, R S Schulof
Cancer Research
|
May 1, 1978
Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems
K P Flora, B van't Riet, G L Wampler
Cancer Research
|
March 1, 1979
New ribonucleotide reductase inhibitors with antineoplastic activity
H L Elford, G L Wampler, B van't Riet
Cancer Investigation
|
January 1, 1987
Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment
G L Wampler, W H Carter, E D Campbell
Cancer Treatment Reports
|
March 1, 1978
Combination chemotherapy: arriving at optimal treatment levels by incorporating side effect constraints
G L Wampler, W H Carter, V R Williams
Cancer Research
|
September 1, 1979
An improved method for analyzing survival data from combination chemotherapy experiments
W H Carter, D M Stablein, G L Wampler
Journal of Medicinal Chemistry
|
May 1, 1979
Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity
B van't Riet, G L Wampler, H L Elford
Biometrics
|
September 1, 1983
Confidence regions for constrained optima in response-surface experiments
D M Stablein, W H Carter, G L Wampler
Cancer Chemotherapy Reports
|
August 1, 1972
Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer
G L Wampler, S J Mellette, M Kuperminc, et al.
Journal of Medicinal Chemistry
|
February 1, 1975
Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents
Y Y Hsiao, T J Bardos, G L Wampler, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 53) with videos related to
Sort By:
Page
of 6
Cancer Investigation
|
January 1, 1992
A pilot study of intensive weekly chemotherapy for extensive disease small-cell lung carcinoma
G L Wampler, J D Ahlgren, R S Schulof
Cancer Research
|
May 1, 1978
Antitumor activity of amidoximes (hydroxyurea analogs) in murine tumor systems
K P Flora, B van't Riet, G L Wampler
Cancer Research
|
March 1, 1979
New ribonucleotide reductase inhibitors with antineoplastic activity
H L Elford, G L Wampler, B van't Riet
Cancer Investigation
|
January 1, 1987
Combination of 5-fluorouracil and cyclophosphamide in L1210 and P388 leukemias with changes in optimum treatments as a function of the age of the L1210 tumor at first treatment
G L Wampler, W H Carter, E D Campbell
Cancer Treatment Reports
|
March 1, 1978
Combination chemotherapy: arriving at optimal treatment levels by incorporating side effect constraints
G L Wampler, W H Carter, V R Williams
Cancer Research
|
September 1, 1979
An improved method for analyzing survival data from combination chemotherapy experiments
W H Carter, D M Stablein, G L Wampler
Journal of Medicinal Chemistry
|
May 1, 1979
Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity
B van't Riet, G L Wampler, H L Elford
Biometrics
|
September 1, 1983
Confidence regions for constrained optima in response-surface experiments
D M Stablein, W H Carter, G L Wampler
Cancer Chemotherapy Reports
|
August 1, 1972
Hexamethylmelamine (NSC-13875) in the treatment of advanced cancer
G L Wampler, S J Mellette, M Kuperminc, et al.
Journal of Medicinal Chemistry
|
February 1, 1975
Synthfsis of bis(aziridinyl)phosphinyl-N-hydroxyurethane derivatives as antineoplastic agents
Y Y Hsiao, T J Bardos, G L Wampler, et al.
Page
of 6